Dr. Karl-Ludwig Kley
Chairman of the Supervisory Board of E.ON SE
Dr. Karl-Ludwig Kley, born on June 11, 1951 in Munich, Germany, holds a doctorate in law and completed an industrial business apprenticeship.
In 1982, he began his career with Bayer AG, where he initially worked in Corporate Finance and later became assistant to the Chairman of the Management Board. He was Chief Financial Officer of Bayer in Japan, Head of the Pharmaceutical Division Sales and Marketing Overseas, Head of the Pharmaceutical Division of Bayer’s Italian subsidiary and later served as Head of Finance and Investor Relations of Bayer AG until 1998. From 1998 to 2006, Dr. Kley was a member of the Executive Board of Deutsche Lufthansa AG, where he served as Chief Financial Officer, before joining Merck KGaA as a member and Vice Chairman of the Executive Board in 2006. From April 2007 until April 2016 he was Chairman of the Executive Board and CEO of Merck KGaA.
Chairman of the Supervisory Board of E.ON SE; term will end at the close of the Annual General Meeting in 2023.
Specific expertise and experience for membership on the Supervisory Board of E.ON SE:
Dr. Kley has gained extensive leadership and supervisory board experience from the management and supervision of DAX and Dow Jones companies. Dr. Kley has profound capital market and industry expertise, as well as a great deal of international experience. He is experienced in the management of complex strategic processes and has substantial experience in innovation and technological expertise in a wide range of business lines.
Other supervisory board seats:
* Deutsche Lufthansa AG (Chairman)1)
* BMW AG1)
The supervisory board seats are marked as follows:
* Membership in other statutory supervisory boards
Listed companies and seats on boards of Group companies are marked as such.
Information as of May 2018